Statistics on Biotechnology Use  
Results by sector of operation
Total sectors. Biotechnology results by main variables and fields of operation. 
Unidades: specified in variables

,Total,Units,P.A.,Higher Education,PNPI,
Units that perform R+D in Biotechnology,1.328,1.133,123,64,8,
%Units according to biotechnology used: Genetic code,40,32,90,89,63,
%Units according to biotechnology used: Functional units,48,41,87,95,25,
%Units according to biotechnology used: Cellular and tissue culturing and engineering,34,27,74,84,63,
%Units according to biotechnology used: Bioprocesses,51,48,56,92,50,
%Units according to biotechnology used: Sub-cellular organisms,16,8,53,72,25,
%Units according to biotechnology used: Bio-computing,29,21,70,86,25,
%Units according to biotechnology used: Nanobiotechnology,20,14,45,73,13,
%Units according to biotechnology used: Other,13,13,11,13,13,
Units in which biotechnology activities are:  Main and/or exclusive,608,564,36,3,5,
Units in which biotechnology activities are: A secondary line of business,294,212,37,43,2,
Units in which biotechnology activities are: A tool necessary for production,427,358,50,18,1,
%Units by field(s) of ultimate application of biotechnology use: Human health,55,50,77,92,75,
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,21,19,19,59,13,
%Units by field(s) of ultimate application of biotechnology use: Food products,31,29,20,86,13,
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:,24,21,20,72,25,
%Units by field(s) of ultimate application of biotechnology use: Environment,17,13,23,73,25,
%Units by field(s) of ultimate application of biotechnology use: Industry,16,13,12,70,25,
Personnel in R&D in biotechnology (no. of persons),35.705,10.706,12.279,12.405,315,
Personnel in R&D in biotechnology (no. of persons): Researchers,23.534,6.227,7.396,9.662,249,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,12.171,4.479,4.883,2.743,66,
Personnel in R&D in biotechnology (no. of persons): women,19.535,5.795,7.333,6.213,194,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,12.149,3.269,4.137,4.591,152,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,7.387,2.527,3.196,1.622,42,
Personnel in R&D in biotechnology (FTE),24.830,2,7.716,4,9.470,2,7.544,3,99,3,
Personnel in R&D in biotechnology (FTE): Researchers,15.765,2,4.603,1,5.358,9,5.744,2,59,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,9.065,3.113,3,4.111,3,1.800,1,40,3,
Personnel in R&D in biotechnology (FTE): women,14.026,5,4.292,9,5.768,1,3.898,4,67,1,
Personnel in R&D in biotechnology (FTE): (women) Researchers,8.366,6,2.446,4,3.075,3,2.804,9,40,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,5.659,9,1.846,5,2.692,8,1.093,5,27,1,
Internal expenditure on R&D (thousands of euros),1.579.928,616.053,578.188,380.311,5.376,
1) By nature of the expense: Current expenses,1.488.894,574.245,551.435,358.168,5.046,
1.1) Remuneration to researchers,639.606,221.741,207.123,208.812,1.930,
1.2) Remuneration to technicians and assistants,273.257,102.464,114.013,56.002,779,
1.3) Other current expenses,576.031,250.041,230.300,93.354,2.337,
2) By nature of the expense: Capital expenses,91.034,41.808,26.752,22.144,330,
2.1) Land and buildings,15.476,5.359,4.304,5.813,.,
2.2) Equipment and instruments,66.410,29.489,21.427,15.163,330,
2.3) Acquisition of specific R+D software,4.363,2.306,956,1.102,.,
2.4) Otros productos de propiedad intelectual específicos para I+D,4.785,4.654,65,66,.,
1) By origin of the funds: National funds,1.383.507,511.960,533.002,333.525,5.020,
1.1) Own funds,510.526,382.335,66.621,60.810,761,
1.2) From companies,119.013,45.024,42.520,29.798,1.672,
1.3) Public Administration funds,702.795,72.387,393.166,236.358,884,
1.4) From Universities,2.790,363,2.018,308,100,
1.5) From non profit private institutions,48.382,11.851,28.676,6.251,1.603,
1) By origin of the funds: Foreign funds,196.421,104.093,45.186,46.786,356,
2.1) From EU programmes,101.384,21.825,39.684,39.875,.,
2.2) Other foreign funds,95.037,82.269,5.501,6.911,356,
Purchase of services R & D in Biotechnology to (thousands of euros),167.608,144.342,20.609,2.618,38,
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain,92.199,70.458,19.167,2.536,38,
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad,75.409,73.885,1.442,82,.,
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital,49,48,56,53,75,
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information,12,13,7,9,0,
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources,18,15,39,36,25,
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,15,12,26,27,38,
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,18,16,31,41,25,
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels,19,16,34,36,38,
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,15,16,12,14,38,
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,36,36,35,27,50,
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost,49,49,50,55,50,
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,18,18,20,14,38,
%Units that have requested biotechnology patents in Biotechnology,21,16,45,73,.,
Number of patents requested,1.809,633,690,486,.,
Notas:

.
'..'=data not available 

 '.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent 

 (*) Total calculated from the total number of companies with related activities  with Biotechnology and the total units from other sectors with activities  in R&D in Biotechnology
Fuente: National Statistics Institute